Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial

Overview of attention for article published in Patient preference and adherence, September 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

patent: 1 patent

Readers on

mendeley: 14 Mendeley

Summary Policy documents Patents

So far, Altmetric has seen 1 patent that references this research output.

METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT

Application US-20140187517-A1

United States of America